AARTIDRUGS2023-04-012023-06-30 AARTIDRUGS2023-04-012023-06-30in-bse-fin:OneOperatingExpenses01Member AARTIDRUGS2023-06-30 iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares 524348 AARTIDRUGS NOTLISTED Aarti Drugs Limited Equity 2023-04-01 2024-03-31 2023-07-21 2023-07-14 INR Lakhs First quarter 11:00:00 16:30:00 2023-07-21 2023-07-21 Not applicable Single segment Pharmaceuticals 2023-04-01 2023-06-30 Audited Consolidated 6611100000.00 6000000.00 6617100000.00 4086100000.00 394200000.00 -16800000.00 254700000.00 85400000.00 126000000.00 1052200000.00 5981800000.00 635300000.00 0.00 635300000.00 147900000.00 7700000.00 155600000.00 0.00 479700000.00 0.00 0.00 0.00 0.00 479700000.00 0.00 479700000.00 478500000.00 1200000.00 926000000.00 10 5.18 5.18 0.00 0.00 5.18 5.18 Notes: 1) The above results for the quarter ended 30th June, 2023 have been reviewed by the Audit Committee and approved by the Board of Directors in their meeting held on 21st July, 2023.  2) Company has only one business segment i.e. pharmaceuticals. 3) Figures for the previous Quarter have been regrouped or rearranged wherever necessary. 4) The aforesaid Audited Financial Results will be uploaded on the Company's website www.aartidrugs.com and will also be available on the website of BSE Limited www.bseindia.com and the National Stock Exchange of India Limited www.nseindia.com for the benefit of the shareholders and investors. For AARTI DRUGS LIMITED Prakash M. Patil (Chairman, Managing Director & CEO) Place: Mumbai Date: 21st July 2023 Other Expenses 1052200000.00 0.00